Graphene Animation Graphene Animation
LinkedIn instagram

Privacy Policy    Terms & Conditions

Oncology

“Shockwave Death” via Cytokine Tagging

This excerpt is taken from the development of a Mechanism of Disease (MoD) animation explores the potential of Cytokine Tagging for Oncology treatment. 

1. Immune Cell-Directed Release of Cytokines or Ligands:

After recognition of a tumor cell, a white blood cell such as a cytotoxic T cell, NK cell, or activated macrophage releases signaling molecules onto the surface of the tumor cell.  These include:

  • TNF-α (Tumor Necrosis Factor alpha)
  • Fas ligand (FasL) or TRAIL (TNF-related apoptosis-inducing ligand)
  • Interferon-gamma (IFN-γ)

These cytokines and ligands bind to death receptors or cytokine receptors on the surface of the tumor cell, initiating apoptotic or necroptotic pathways. [1,2]

2. Receptor Engagement and Intracellular Activation (Silent Kill Switch):

Once these ligands are bound:

  • TRAIL binds to death receptors DR4/DR5
  • FasL binds to Fas (CD95)
  • TNF-α binds to TNFR1/2

These trigger caspase cascades internally in the tumor cell, often after the immune cell has moved on — a kind of "tag and trigger" approach. [1,2]

 3. Surface Disruption and Cell Death (Shockwave Representation):

The downstream effects of these signals lead to:

Membrane blebbing, Cytoskeletal collapse, Mitochondrial damage, Eventual cell membrane destabilization

This moment of collapse or membrane failure can be visually interpreted as a shockwave-like surface ripple, representing the catastrophic failure of membrane integrity as apoptosis or necroptosis completes. [1]

References:

  1. Ashkenazi, A. (2008). Directing cancer cells to self-destruct with pro-apoptotic receptor agonists. Nature Reviews Drug Discovery, 7(12), 1001–1012.

  2. Reference: Wang, S., & El-Deiry, W.S. (2003). TRAIL and apoptosis induction by TNF-family death receptors. Oncogene, 22(53), 8628–8633.

Oncology Medical Animation FAQs

What can an oncology animation show that a still image cannot?

Oncology biology is dynamic. A treatment may need to reach a tumour, recognise a specific target, alter signalling, recruit or activate immune cells, and produce downstream effects — all in a defined sequence. Animation makes that sequence visible, showing where events occur, which cells or molecules are involved, and how one interaction leads to the next.

How can animation explain the tumour microenvironment?

A tumour exists within a changing environment that may include blood vessels, immune cells, surrounding tissue, and signalling molecules. Animation can establish that environment clearly, then guide the viewer towards the interaction that matters, rather than presenting every biological detail at once.

How do you simplify oncology science without misrepresenting it?

The aim is not to show every known biological interaction. It is to make a specific, evidence-based story understandable while being clear about what is represented. The script and storyboard should identify the essential events, avoid unsupported implications, and remain appropriate for the intended audience and review pathway.

Next Steps

If you are interested in speaking to a medical animation expert, please get in touch.

Get in touch